Arachidonic acid metabolites in otitis media pathogenesis.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism*; D002682:Chinchilla; D016861:Cyclooxygenase Inhibitors; D015232:Dinoprostone; D004432:Ear, Middle / Q000378:metabolism*; D006099:Granuloma / Q000378:metabolism; D007052:Ibuprofen / Q000627:therapeutic use; D007249:Inflammation / Q000378:metabolism; D008084:Lipoxygenase / Q000378:metabolism; D016859:Lipoxygenase Inhibitors; D009092:Mucous Membrane / Q000378:metabolism; D010033:Otitis Media / Q000378:metabolism*; D010034:Otitis Media with Effusion / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism* / Q000382:microbiology; D010035:Otitis Media, Suppurative / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism* / Q000382:microbiology; D010406:Penicillins / Q000627:therapeutic use; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011458:Prostaglandins E / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D016859:Lipoxygenase Inhibitors; D010406:Penicillins; D011458:Prostaglandins E; D008084:Lipoxygenase; D011451:Prostaglandin-Endoperoxide Synthases; D015232:Dinoprostone; D007052:Ibuprofen